Category Pharm Industry Trends

AP Health NewsBrief at 12:49 a.m. EST

Nov6

In Europe, most swine flu shots by invitation onlyLONDON (AP) – In Britain, there are no long lines of people seeking swine flu vaccine. Doctor’s offices aren’t swamped with desperate calls. And there are no cries of injustice that the vaccine is going to wealthy corporations or healthy people who don’t really need it. Here, […]

Ready for the rush: Large turnout expected for swine flu vaccine clinic [High Point Enterprise, N.C.]

Nov6

Data on mass spectrometry detailed by researchers at Vanderbilt University, Vanderbilt Institute of Chemical Biology

Nov6

Researchers detail in ‘Characterizing ion mobility-mass spectrometry conformation space for the analysis of complex biological samples,’ new data in mass spectrometry. According to recent research published in the journal Analytical and Bioanalytical Chemistry, "The conformation space occupied by different classes of biomolecules measured by ion mobility-mass spectrometry (IM-MS) is described for utility in the characterization […]

Findings from University of California provide new insights into proteomics

Nov6

"Conformational restriction by fragment assembly and guidance in molecular dynamics are alternate conformational search strategies in protein structure prediction. We examine both approaches using a version of the associative memory Hamiltonian that incorporates the influence of water-mediated interactions (AMW)," scientists writing in the journal Proceedings of the National Academy of Sciences of the United States […]

RXi Pharmaceuticals Appoints Noah D. Beerman as CEO

Nov5

Business Veteran Brings to RXi a Successful Track Record of Building a Pipeline of Biopharmaceutical Products WORCESTER, Mass.(BUSINESS WIRE) RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Noah D. Beerman has joined the company as its new President and […]

BENZEFOAM(TM) Emollient Foam Demonstrates Significant Reduction in Propionibacterium acnes in Study Presented at the Fall Clinical Dermatology…

Nov5

BENZEFOAM(TM) Emollient Foam Demonstrates Significant Reduction in Propionibacterium acnes in Study Presented at the Fall Clinical Dermatology Conference2009 NOV 6 – (NewsRx.com) Onset Therapeutics, a specialty pharmaceutical company focused on dermatology, announced that positive data on the reduction of the acne-causing bacteria Propionibacterium acnes with BenzEFoam? (benzoyl peroxide) 5.3% Emollient Foam was presented at a […]

Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results

Nov5

LYNBROOK, N.Y., Nov. 6 /PRNewswire-FirstCall/ BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter ended September 30, 2009. "We were extremely happy that, in September of this year, the FDA’s Arthritis Advisory Committee unanimously recommended, by a vote of 12-0, the approval of […]

Domestic horse genome sequenced

Nov5

Washington, Nov 6 (ANI): The genome of a domestic horse has been successfully sequenced by an international team of researchers.According to scientists, findings have important implications for improved breeding of horses and for studies of human health."This very high-quality genome sequence of the horse is important because it gives us access to specific sequence information […]

Studies from A. Shafy and colleagues yield new information about cell therapy

Nov5

2009 NOV 6 – (NewsRx.com) According to recent research published in the Journal of Thoracic and Cardiovascular Surgery, "Until now, cell therapy has constituted a passive therapeutic approach; the only effects seem to be related to the reduction of the myocardial fibrosis and the limitation of the adverse ventricular remodeling (see also Cell Therapy). Cardiac […]

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting

Nov5

CALGARY, Nov. 6 /PRNewswire-FirstCall/ – Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung in a poster presentation at the 15th Annual Connective Tissue Oncology Society Meeting held in Miami Beach, Florida, from November 5th […]